Utama › Limfoma Folikular › California › Baldwin Park
Kajian klinikal Limfoma Folikular di Baldwin Park, CA
16 kajian untuk Limfoma Folikular sedang mencari peserta di lokasi dalam dan sekitar Baldwin Park (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Mengambil pesertaFasa 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauh
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Mengambil pesertaFasa 2/3
- City of Hope - Duarte Cancer Center ( Site 1301), Duarte · 4 mi jauh
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
Mosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular Lymphoma
Mengambil pesertaFasa 2
- City of Hope Medical Center, Duarte · 4 mi jauh
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Mengambil pesertaFasa 2
- Research Site, Duarte · 4 mi jauh
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Mengambil pesertaFasa 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauh
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Mengambil pesertaFasa 1/2
- City of Hope, Duarte · 4 mi jauh
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
Mengambil pesertaFasa 1
- City of Hope Medical Center, Duarte · 4 mi jauh
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Mengambil pesertaFasa 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauh
Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1
- City of Hope Medical Center, Duarte · 4 mi jauh
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Mengambil pesertaFasa 1/2
- City of Hope, Duarte · 4 mi jauh
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Duarte · 4 mi jauh
Kajian Limfoma Folikular di bandar lain
- New York City, NY24 kajian
- Milwaukee, WI19 kajian
- Nashville, TN18 kajian
- Houston, TX18 kajian
- Boston, MA17 kajian
- Seattle, WA15 kajian
- Durham, NC15 kajian
- Columbus, OH13 kajian
- Salt Lake City, UT13 kajian
- Chicago, IL12 kajian
- San Antonio, TX12 kajian
- Philadelphia, PA12 kajian
Kajian lain di Baldwin Park
- Kanser Payudara45 kajian
- Leukemia Mieloid Akut40 kajian
- Kanser Kolorektal38 kajian
- Kanser Paru-paru Bukan Sel Kecil36 kajian
- Kanser (semua jenis)33 kajian
- Kanser Prostat30 kajian
- Kanser Metastatik30 kajian
- Sindrom Mielodisplastik26 kajian
- Kanser Ovari25 kajian
- Kanser Paru-paru24 kajian
- Mieloma Pelbagai23 kajian
- Kanser Perut22 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.